Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide vs Hyoscine Butylbromide for Labor Duration
NCT05222646Phase 1Unknown
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in prolonged labor comparing Metoclopramide group, Hyoscine bromide group and Placebo group (3 arms). Primary endpoint: Duration of the first stage of labor at 6 months. Status: unknown.
02
Drugs
metoclopramidehyoscine butylbromide
03
Conditions
prolonged labor
Beyond the preview
Go deeper on NCT05222646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05222646.